3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
4
Colorectal Neoplasms
3
Triple Negative Breast Neoplasms
2
Rectal Neoplasms
1
Myelodysplastic Syndromes
1
Melanoma
1
Leukemia, Myelomonocytic, Chronic
1
Kidney Neoplasms
1
Hereditary Sensory and Autonomic Neuropathies
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Gemcitabine
5
Paclitaxel
4
Nivolumab
3
cobimetinib
2
atezolizumab
2
adavosertib
2
Ramucirumab
2
N-((5-bromo-2-thienyl)sulfonyl)-2,4-dichlorobenzamide
2
Carboplatin
2
zansecimab
1
tocilizumab
1
tivozanib
1
tislelizumab
1
temsirolimus
1
ridaforolimus
1
plocabulin
1
pexidartinib
1
pevonedistat
1
pembrolizumab
1
pamiparib
1
obinutuzumab
1
necitumumab
1
liposomal doxorubicin
1
lenvatinib
1
glasdegib
1
futuximab
1
demplatin pegraglumer
1
birinapant
1
avelumab
1
Temozolomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Solid Tumors
×
CB-839
×
Clear all
No trials found.